In search of the neuroprotective mechanism of thiazolidinediones in Parkinson's disease

Dirk A. Ridder; Markus Schwaninger

doi:10.1016/j.expneurol.2012.08.012

In search of the neuroprotective mechanism of thiazolidinediones in Parkinson's disease

Dirk A. Ridder, Markus Schwaninger^*

^*Corresponding author for this work

Institute of Experimental and Clinical Pharmacology and Toxicology

10 Citations (Scopus)

Abstract

The oral antidiabetic thiazolidinediones exert protective effects in models of Parkinson's disease and other neurological diseases. While the antidiabetic effect is due to activation of PPAR?, the mechanisms underlying the neuroprotection are more controversial. It may involve activation of PPAR? blocking inflammation and apoptosis. However, new evidence suggests an antioxidative PPAR?-independent action. Here we discuss recent data on the mode of action of TZDs in models of PD and their implication for the translation into the clinic.

Original language	English
Journal	Experimental Neurology
Volume	238
Issue number	2
Pages (from-to)	133-137
Number of pages	5
ISSN	0014-4886
DOIs	https://doi.org/10.1016/j.expneurol.2012.08.012
Publication status	Published - 01.12.2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.expneurol.2012.08.012

Cite this

@article{b3cd33f802b94f76b3fb03e9df893faa,

title = "In search of the neuroprotective mechanism of thiazolidinediones in Parkinson's disease",

abstract = "The oral antidiabetic thiazolidinediones exert protective effects in models of Parkinson's disease and other neurological diseases. While the antidiabetic effect is due to activation of PPAR?, the mechanisms underlying the neuroprotection are more controversial. It may involve activation of PPAR? blocking inflammation and apoptosis. However, new evidence suggests an antioxidative PPAR?-independent action. Here we discuss recent data on the mode of action of TZDs in models of PD and their implication for the translation into the clinic.",

author = "Ridder, {Dirk A.} and Markus Schwaninger",

year = "2012",

month = dec,

day = "1",

doi = "10.1016/j.expneurol.2012.08.012",

language = "English",

volume = "238",

pages = "133--137",

journal = "Experimental Neurology",

issn = "0014-4886",

number = "2",

}

TY - JOUR

T1 - In search of the neuroprotective mechanism of thiazolidinediones in Parkinson's disease

AU - Ridder, Dirk A.

AU - Schwaninger, Markus

PY - 2012/12/1

Y1 - 2012/12/1

N2 - The oral antidiabetic thiazolidinediones exert protective effects in models of Parkinson's disease and other neurological diseases. While the antidiabetic effect is due to activation of PPAR?, the mechanisms underlying the neuroprotection are more controversial. It may involve activation of PPAR? blocking inflammation and apoptosis. However, new evidence suggests an antioxidative PPAR?-independent action. Here we discuss recent data on the mode of action of TZDs in models of PD and their implication for the translation into the clinic.

AB - The oral antidiabetic thiazolidinediones exert protective effects in models of Parkinson's disease and other neurological diseases. While the antidiabetic effect is due to activation of PPAR?, the mechanisms underlying the neuroprotection are more controversial. It may involve activation of PPAR? blocking inflammation and apoptosis. However, new evidence suggests an antioxidative PPAR?-independent action. Here we discuss recent data on the mode of action of TZDs in models of PD and their implication for the translation into the clinic.

UR - http://www.scopus.com/inward/record.url?scp=84866544305&partnerID=8YFLogxK

U2 - 10.1016/j.expneurol.2012.08.012

DO - 10.1016/j.expneurol.2012.08.012

M3 - Comments/Debates

C2 - 23085103

AN - SCOPUS:84866544305

SN - 0014-4886

VL - 238

SP - 133

EP - 137

JO - Experimental Neurology

JF - Experimental Neurology

IS - 2

ER -

In search of the neuroprotective mechanism of thiazolidinediones in Parkinson's disease

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this